Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

Clinical trial NCT06238245 · UNKNOWN

Trial details

NCT number: NCT06238245
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Graft-versus-host Disease Hematological Malignancies

Start date: 2024-02-28
Primary completion: 2025-12-30
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.